IP Library Granted Patent US 9,822,172
Granted Patent B2
US 9,822,172 · App. 15/035,205 · Granted Nov 21, 2017

Assays for IGFBP7 having improved performance in biological samples

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,822,172
App. No.
15/035,205
Granted
Nov 21, 2017
Kind
B2
Abstract

The invention provides IGFBP7 immunoassays with improved clinical performance, particularly when used in the evaluation of renal injuries. The immunoassays rely on the selection and use of antibodies and antibody pairs that exhibit improved assay performance when used in complex clinical specimens such as biological fluids, and particularly when used in rapid assay formats such as lateral flow test devices.

Claims (8)

1. An isolated antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 9 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 10.

2. An antibody according to claim 1 , wherein the antibody is a monoclonal antibody.

3. A nucleic acid, the sequence of which encodes an antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 9 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 10.

4. An antibody-expressing cell line, the cell line expressing an antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 9 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 10.

5. An isolated antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 11 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 12.

6. An antibody according to claim 5 , wherein the antibody is a monoclonal antibody.

7. A nucleic acid, the sequence of which encodes an antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 11 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 12.

8. An antibody-expressing cell line, the cell line expressing an antibody comprising a light chain variable region having an amino acid sequence of SEQ ID NO: 11 and a heavy chain variable region having an amino acid sequence of SEQ ID NO: 12.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2025
From: ASTUTE MEDICAL, INC.
To: BIOMERIEUX, INC.
Reel/Frame 069778/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2016
From: VIJAYENDRAN, RAVI A.; VENKATASUBBARAO, SRIVATSA
To: ASTUTE MEDICAL, INC,
Reel/Frame 038834/0033 →